BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 34530005)

  • 21. Segmental dependent transport of low permeability compounds along the small intestine due to P-glycoprotein: the role of efflux transport in the oral absorption of BCS class III drugs.
    Dahan A; Amidon GL
    Mol Pharm; 2009; 6(1):19-28. PubMed ID: 19248230
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Different absorption behaviors among steroid hormones due to possible interaction with P-glycoprotein in the rat small intestine.
    Nakayama A; Eguchi O; Hatakeyama M; Saitoh H; Takada M
    Biol Pharm Bull; 1999 May; 22(5):535-8. PubMed ID: 10375178
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decreased intestinal CYP3A and P-glycoprotein activities in rats with adjuvant arthritis.
    Uno S; Kawase A; Tsuji A; Tanino T; Iwaki M
    Drug Metab Pharmacokinet; 2007 Aug; 22(4):313-21. PubMed ID: 17827786
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The H2 receptor antagonist nizatidine is a P-glycoprotein substrate: characterization of its intestinal epithelial cell efflux transport.
    Dahan A; Sabit H; Amidon GL
    AAPS J; 2009 Jun; 11(2):205-13. PubMed ID: 19319690
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative effects on intestinal absorption in situ by P-glycoprotein-modifying HIV protease inhibitors.
    Richter M; Gyémánt N; Molnár J; Hilgeroth A
    Pharm Res; 2004 Oct; 21(10):1862-6. PubMed ID: 15553233
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regional difference in P-glycoprotein function in rat intestine.
    Iida A; Tomita M; Hayashi M
    Drug Metab Pharmacokinet; 2005 Apr; 20(2):100-6. PubMed ID: 15855720
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intestinal permeability of metformin using single-pass intestinal perfusion in rats.
    Song NN; Li QS; Liu CX
    World J Gastroenterol; 2006 Jul; 12(25):4064-70. PubMed ID: 16810761
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Downregulated expression of intestinal P-glycoprotein in rats with cisplatin-induced acute kidney injury causes amplification of its transport capacity to maintain "gatekeeper" function.
    Takeda F; Oda M; Terasaki M; Ichimura Y; Kojima H; Saitoh H
    Toxicol Appl Pharmacol; 2021 Jul; 423():115570. PubMed ID: 33965372
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Region-dependent disappearance of vinblastine in rat small intestine and characterization of its P-glycoprotein-mediated efflux system.
    Nakayama A; Saitoh H; Oda M; Takada M; Aungst BJ
    Eur J Pharm Sci; 2000 Oct; 11(4):317-24. PubMed ID: 11033075
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ezetimibe Promotes Brush Border Membrane-to-Lumen Cholesterol Efflux in the Small Intestine.
    Nakano T; Inoue I; Takenaka Y; Ono H; Katayama S; Awata T; Murakoshi T
    PLoS One; 2016; 11(3):e0152207. PubMed ID: 27023132
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute regulation of intestinal ion transport and permeability in response to luminal nutrients: the role of the enteric nervous system.
    Cavin JB; Cuddihey H; MacNaughton WK; Sharkey KA
    Am J Physiol Gastrointest Liver Physiol; 2020 Feb; 318(2):G254-G264. PubMed ID: 31709828
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of Labrasol and other pharmaceutical excipients on the intestinal transport and absorption of rhodamine123, a P-glycoprotein substrate, in rats.
    Lin Y; Shen Q; Katsumi H; Okada N; Fujita T; Jiang X; Yamamoto A
    Biol Pharm Bull; 2007 Jul; 30(7):1301-7. PubMed ID: 17603171
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of Simplified in Vitro P-Glycoprotein Substrate Assay and in Silico Prediction Models To Evaluate Transport Potential of P-Glycoprotein.
    Ohashi R; Watanabe R; Esaki T; Taniguchi T; Torimoto-Katori N; Watanabe T; Ogasawara Y; Takahashi T; Tsukimoto M; Mizuguchi K
    Mol Pharm; 2019 May; 16(5):1851-1863. PubMed ID: 30933526
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantitative prediction of P-glycoprotein-mediated drug-drug interactions and intestinal absorption using humanized mice.
    Miyake T; Tsutsui H; Haraya K; Tachibana T; Morimoto K; Takehara S; Ayabe M; Kobayashi K; Kazuki Y
    Br J Pharmacol; 2021 Nov; 178(21):4335-4351. PubMed ID: 34232502
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanism of beta-adrenergic agonist-induced transmural transport of glucose in rat small intestine. Regulation of phosphorylation of SGLT1 controls the function.
    Ishikawa Y; Eguchi T; Ishida H
    Biochim Biophys Acta; 1997 Jul; 1357(3):306-18. PubMed ID: 9268055
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chrysosplenetin inhibits artemisinin efflux in P-gp-over-expressing Caco-2 cells and reverses P-gp/MDR1 mRNA up-regulated expression induced by artemisinin in mouse small intestine.
    Ma L; Wei S; Yang B; Ma W; Wu X; Ji H; Sui H; Chen J
    Pharm Biol; 2017 Dec; 55(1):374-380. PubMed ID: 27931149
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of class B scavenger receptors on cholesterol flux across the brush border membrane and intestinal absorption.
    Nguyen DV; Drover VA; Knopfel M; Dhanasekaran P; Hauser H; Phillips MC
    J Lipid Res; 2009 Nov; 50(11):2235-44. PubMed ID: 19454765
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel experimental parameters to quantify the modulation of absorptive and secretory transport of compounds by P-glycoprotein in cell culture models of intestinal epithelium.
    Troutman MD; Thakker DR
    Pharm Res; 2003 Aug; 20(8):1210-24. PubMed ID: 12948019
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multiple efflux pumps are involved in the transepithelial transport of colchicine: combined effect of p-glycoprotein and multidrug resistance-associated protein 2 leads to decreased intestinal absorption throughout the entire small intestine.
    Dahan A; Sabit H; Amidon GL
    Drug Metab Dispos; 2009 Oct; 37(10):2028-36. PubMed ID: 19589874
    [TBL] [Abstract][Full Text] [Related]  

  • 40. P-glycoprotein activation by 1-(propan-2-ylamino)-4-propoxy-9H-thioxanthen-9-one (TX5) in rat distal ileum: ex vivo and in vivo studies.
    Rocha-Pereira C; Ghanem CI; Silva R; Casanova AG; Duarte-Araújo M; Gonçalves-Monteiro S; Sousa E; Bastos ML; Remião F
    Toxicol Appl Pharmacol; 2020 Jan; 386():114832. PubMed ID: 31756430
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.